应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PFE 辉瑞
休市中 12-05 16:00:00 EST
26.03
+0.33
+1.28%
盘后
25.97
-0.06
-0.23%
19:59 EST
最高
26.12
最低
25.64
成交量
4,744万
今开
25.77
昨收
25.70
日振幅
1.87%
总市值
1,480亿
流通市值
1,477亿
总股本
56.86亿
成交额
12.30亿
换手率
0.84%
流通股本
56.76亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
美股疫苗股大跌,FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联
老虎资讯综合 · 12-02
美股疫苗股大跌,FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联
Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请
美股速递 · 11-26
Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请
古根海姆上调辉瑞目标价至35美元
格隆汇 · 11-25
古根海姆上调辉瑞目标价至35美元
Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)
美股速递 · 11-24
Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)
辉瑞友瑞宁(马塔西单抗)在华获批
南方财经网 · 11-21
辉瑞友瑞宁(马塔西单抗)在华获批
Starboard Value LP解除在辉瑞与Fortrea的股份
投资观察 · 11-20
Starboard Value LP解除在辉瑞与Fortrea的股份
辉瑞通过区块交易出售在BioNTech的剩余持股
投资观察 · 11-20
辉瑞通过区块交易出售在BioNTech的剩余持股
辉瑞首席执行官阿尔伯特·布尔拉表示,Think Co将全额支付Metsera的CVR
投资观察 · 11-20
辉瑞首席执行官阿尔伯特·布尔拉表示,Think Co将全额支付Metsera的CVR
HHS宣布FDA批准两种新药用于更年期症状
投资观察 · 11-20
HHS宣布FDA批准两种新药用于更年期症状
辉瑞向Metsera提交了增价收购提案,与诺和诺德的出价相匹配,评估Metsera每股价值为86.20美元
投资观察 · 11-20
辉瑞向Metsera提交了增价收购提案,与诺和诺德的出价相匹配,评估Metsera每股价值为86.20美元
辉瑞与Tris Pharma就德克萨斯州儿童ADHD药物的质量控制问题达成4150万美元和解
美股速递 · 11-19
辉瑞与Tris Pharma就德克萨斯州儿童ADHD药物的质量控制问题达成4150万美元和解
和铂医药-B子公司与辉瑞签非独家授权协议
财中社 · 11-19
和铂医药-B子公司与辉瑞签非独家授权协议
Nona Biosciences:可能与辉瑞合作进行抗体发现、开发和工程,利用Nona的Hcab平台
美股速递 · 11-19
Nona Biosciences:可能与辉瑞合作进行抗体发现、开发和工程,利用Nona的Hcab平台
辉瑞 - Nona Biosciences将获得预付款并有资格获得监管、临床和商业里程碑付款
美股速递 · 11-19
辉瑞 - Nona Biosciences将获得预付款并有资格获得监管、临床和商业里程碑付款
Nona Biosciences与辉瑞宣布战略研究合作 加速抗体发现
美股速递 · 11-19
Nona Biosciences与辉瑞宣布战略研究合作 加速抗体发现
Nona Bioscience:辉瑞将获得全球使用Nona专有Hcab平台的权利,以生成完全人类重链抗体
美股速递 · 11-19
Nona Bioscience:辉瑞将获得全球使用Nona专有Hcab平台的权利,以生成完全人类重链抗体
辉瑞公布55亿美元六期债券的定价条款; 2027年到期的5亿美元浮动利率债券 - SEC备案
美股速递 · 11-19
辉瑞公布55亿美元六期债券的定价条款; 2027年到期的5亿美元浮动利率债券 - SEC备案
辉瑞(PFE.US)拟发行50亿美元债券 为收购减肥药企Metsera筹措资金
智通财经 · 11-19
辉瑞(PFE.US)拟发行50亿美元债券 为收购减肥药企Metsera筹措资金
预计11月19日在华盛顿举行的美沙投资论坛将包括雪佛龙、高通、思科、通用动力和辉瑞的首席执行官
美股速递 · 11-18
预计11月19日在华盛顿举行的美沙投资论坛将包括雪佛龙、高通、思科、通用动力和辉瑞的首席执行官
异动解读 | 辉瑞斥资100亿美元收购减肥药新贵,股价盘前大跌5%
异动解读 · 11-14
异动解读 | 辉瑞斥资100亿美元收购减肥药新贵,股价盘前大跌5%
加载更多
公司概况
公司名称:
辉瑞
所属市场:
NYSE
上市日期:
--
主营业务:
辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源,通过发现、开发、制造和分销保健产品(包括创新药物和疫苗),为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作,致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作,支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。
发行价格:
--
{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":26.03,"timestamp":1764968400000,"preClose":25.7,"halted":0,"volume":47443701,"hourTrading":{"tag":"盘后","latestPrice":25.97,"preClose":26.03,"latestTime":"19:59 EST","volume":1432641,"amount":37260469.5583,"timestamp":1764982757086},"delay":0,"floatShares":5675908374,"shares":5685707552,"eps":1.726245,"marketStatus":"休市中","change":0.33,"latestTime":"12-05 16:00:00 EST","open":25.77,"high":26.12,"low":25.64,"amount":1230406222.713927,"amplitude":0.018677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.726245,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":25.7,"dividendRate":0.065309,"preHourTrading":{"tag":"盘前","latestPrice":25.77,"preClose":25.7,"latestTime":"09:29 EST","volume":95036,"amount":2443515.9281719998,"timestamp":1764944999999},"postHourTrading":{"tag":"盘后","latestPrice":25.97,"preClose":26.03,"latestTime":"19:59 EST","volume":1432641,"amount":37260469.5583,"timestamp":1764982757086},"volumeRatio":1.1230326691635157,"optionData":{"bulkOrders":[{"symbol":"PFE","call":false,"expireDate":1771563600000,"strike":"23.0","timestamp":1764948388982,"price":0.33,"volume":15000,"amount":495000,"type":"-"},{"symbol":"PFE","call":true,"expireDate":1764910800000,"strike":"26.5","timestamp":1764949842243,"price":0.01,"volume":3000,"amount":3000,"type":"*"}]},"impliedVol":0.2857,"impliedVolPercentile":0.368},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"1186165748","title":"美股疫苗股大跌,FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联","url":"https://stock-news.laohu8.com/highlight/detail?id=1186165748","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186165748?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:25","pubTimestamp":1764635137,"startTime":"0","endTime":"0","summary":"在疫情期间,Prasad 因反对疫苗强制措施以及对新冠疫苗引发心肌炎风险的关注而在网上获得追随者。其他研究则发现,新冠感染导致心肌炎的风险高于接种疫苗。辉瑞和 BioNTech 共同研发了新冠疫苗 Comirnaty。两家公司均研发并销售新冠 mRNA 疫苗。这并非 Prasad 首次推动与 mRNA 新冠疫苗相关的变更。这位 FDA 官员还呼吁为疫苗临床试验设定不同的终点指标。","market":"us","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"美股疫苗股大跌,FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","DVAX","MRNA","BNTX"],"gpt_icon":1},{"id":"1146660340","title":"Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1146660340","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146660340?lang=zh_cn&edition=full","pubTime":"2025-11-26 14:03","pubTimestamp":1764136992,"startTime":"0","endTime":"0","summary":"Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4581","LU0306807586.USD","LU0225771236.USD","IE00BBT3K403.USD","BK4599","BK4568","IE00B19Z3B42.SGD","IE00BLSP4239.USD","SG9999003800.SGD","LU0456855351.SGD","BK4550","SG9999001176.SGD","LU1023059063.AUD","LU0868494617.USD","LU1066051498.USD","SG9999002232.USD","LU1066053197.SGD","LU1894683264.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999013999.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0321505868.SGD","BK4585","IE00BLSP4452.SGD","BK4533","LU0234572021.USD","LU1894683348.USD","IE0002270589.USD","SG9999002224.SGD","LU0306806265.USD","LU0289739699.SGD","PFE","LU0122379950.USD","BK4592","BK4007","LU0170899867.USD","BK4588","BK4534","LU1057294990.SGD","LU0225284248.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"2586425720","title":"古根海姆上调辉瑞目标价至35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586425720","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586425720?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:34","pubTimestamp":1764063257,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","LU0456855351.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1883839398.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","SG9999003800.SGD","IE00B19Z3581.USD","PFE","BK4588","LU0306806265.USD","LU0321505439.SGD","LU0306807586.USD","LU0289739699.SGD","BK4533","SG9999002232.USD","BK4550","LU0122379950.USD","LU0868494617.USD","LU0985481810.HKD","IE00BLSP4452.SGD","BK4599","SG9999001176.SGD","BK4568","SG9999001176.USD","IE0002270589.USD","BK4007","LU1894683348.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0225771236.USD","BK4592","LU0234572021.USD","SG9999013999.USD","BK4581","LU0170899867.USD","LU0321505868.SGD","SG9999011175.SGD","LU0058720904.USD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","IE00BLSP4239.USD","BK4534","LU1894683264.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"1163182464","title":"Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)","url":"https://stock-news.laohu8.com/highlight/detail?id=1163182464","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163182464?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN","IE00BLSP4239.USD","SGXZ57979304.SGD","LU0234572021.USD","BK4599","LU0225771236.USD","SG9999002232.USD","BK4533","LU1023059063.AUD","BK4592","LU0170899867.USD","LU1883839398.USD","SG9999002224.SGD","LU0321505439.SGD","LU1057294990.SGD","LU1066053197.SGD","LU1066051498.USD","BK4550","IE00BLSP4452.SGD","SG9999013999.USD","BK4588","IE00B19Z3B42.SGD","LU0122379950.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU0868494617.USD","IE000M9KFDE8.USD","LU0058720904.USD","BK4568","LU0306807586.USD","PFE","SG9999001176.USD","BK4585","IE00BBT3K403.USD","LU0306806265.USD","LU1894683264.USD","SG9999003800.SGD","SG9999011175.SGD","BK4581","LU0225284248.USD","BK4007","IE0002270589.USD","LU0289739699.SGD","LU0321505868.SGD","LU0985481810.HKD","LU1894683348.USD","BK4534","LU0456855351.SGD"],"gpt_icon":0},{"id":"2585319634","title":"辉瑞友瑞宁(马塔西单抗)在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2585319634","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585319634?lang=zh_cn&edition=full","pubTime":"2025-11-21 12:18","pubTimestamp":1763698705,"startTime":"0","endTime":"0","summary":"辉瑞友瑞宁(马塔西单抗)在华获批","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511213571249897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4592","SG9999003800.SGD","LU0985481810.HKD","BK4581","BK4533","SG9999013999.USD","LU0289739699.SGD","LU0321505439.SGD","LU0321505868.SGD","SG9999001176.SGD","SG9999002224.SGD","BK4588","LU0225284248.USD","LU0456855351.SGD","LU1057294990.SGD","BK4599","IE00BLSP4239.USD","SG9999002232.USD","BK4007","IE00B19Z3B42.SGD","SGXZ57979304.SGD","BK4550","LU0122379950.USD","LU1066051498.USD","BK4568","BK4585","IE00BLSP4452.SGD","LU0868494617.USD","IE00BBT3K403.USD","LU1894683348.USD","LU0170899867.USD","LU1023059063.AUD","LU1066053197.SGD","LU1894683264.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU0225771236.USD","LU0234572021.USD","SG9999011175.SGD","IE0002270589.USD","LU0306807586.USD","BK4534","LU0306806265.USD","PFE","LU0058720904.USD","LU1883839398.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1148496168","title":"Starboard Value LP解除在辉瑞与Fortrea的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1148496168","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148496168?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:50","pubTimestamp":1763574634,"startTime":"0","endTime":"0","summary":"11月14日(路透社)——STARBOARD VALUE LP:*STARBOARD VALUE LP解除在辉瑞的股份 - SEC文件*STARBOARD VALUE LP在AUTODESK的股份减少10.5%,降至130万股*STARBOARD VALUE LP解除在Fortrea的股份*STARBOARD VALUE LP在MATCH GROUP的股份减少27.7%,降至1110万股*STARBOARD VALUE LP在ROGERS的股份增加至170万股*STARBOARD VALUE LP的持股变动截至2025年9月30日,较截至2025年6月30日的前一个季度有所变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1066053197.SGD","LU0240877869.USD","LU0225771236.USD","BK4550","PFE","LU0225284248.USD","BK4592","BK4508","LU0240878834.USD","BK4148","BK4599","SG9999013999.USD","BK4534","LU0456855351.SGD","SG9999001176.SGD","LU1066051498.USD","LU0868494617.USD","LU0205193047.USD","IE00B19Z3B42.SGD","BK4007","IE00BLSP4239.USD","BK4588","BK4077","BK4533","LU0122379950.USD","SG9999001176.USD","SG9999003800.SGD","LU0306806265.USD","SG9999002224.SGD","BK4568","SG9999002232.USD","ROG","LU0170899867.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU0234572021.USD","LU0321505439.SGD","MTCH","LU0205194284.USD","IE00BBT3K403.USD","BK4585","LU0289739699.SGD","BK4549","IE000M9KFDE8.USD","LU0058720904.USD","SG9999011175.SGD","LU0985481810.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0321505868.SGD","BK4581","LU1023059063.AUD","LU1894683264.USD","IE00B19Z3581.USD","LU1894683348.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"1140001019","title":"辉瑞通过区块交易出售在BioNTech的剩余持股","url":"https://stock-news.laohu8.com/highlight/detail?id=1140001019","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140001019?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:38","pubTimestamp":1763573888,"startTime":"0","endTime":"0","summary":"11月13日 - 据彭博社报道知情人士消息:*辉瑞以每个美国存托凭证108至111.70美元的价格,通过隔夜区块交易出售在BioNTech的剩余持股*未注册发行的455万份存托凭证,以相较于周三收盘价高达3.3%的折扣进行出售 - 彭博社计算数据* 进一步公司报道:BNTX.OPFE.N*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0058720904.USD","LU1894683264.USD","SG9999001176.SGD","SG9999002224.SGD","LU0234572021.USD","LU1057294990.SGD","LU0225284248.USD","IE000M9KFDE8.USD","BK4534","BK4592","BK4599","IE00B19Z3B42.SGD","LU0225771236.USD","LU1894683348.USD","SG9999011175.SGD","LU0456855351.SGD","BK4550","BK4585","LU1066051498.USD","LU0321505439.SGD","BNTX","PFE","SG9999001176.USD","LU0306807586.USD","LU0321505868.SGD","IE00B19Z3581.USD","BK4568","BK4581","BK4007","SG9999002232.USD","LU0170899867.USD","LU0306806265.USD","LU0868494617.USD","LU0985481810.HKD","LU1023059063.AUD","LU1066053197.SGD","LU0289739699.SGD","LU1883839398.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4533","IE00BLSP4239.USD","LU0122379950.USD","SG9999013999.USD","SGXZ57979304.SGD","SG9999003800.SGD","BK4548","BK4139","IE0002270589.USD","BK4588","BK4535"],"gpt_icon":0},{"id":"1173736428","title":"辉瑞首席执行官阿尔伯特·布尔拉表示,Think Co将全额支付Metsera的CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=1173736428","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173736428?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:21","pubTimestamp":1763572880,"startTime":"0","endTime":"0","summary":"11月10日 - 辉瑞首席执行官阿尔伯特·布尔拉在接受CNBC采访时表示,Think Co将全额支付Metsera的CVR。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BK4007","IE000M9KFDE8.USD","TURA","LU1883839398.USD","LU1066053197.SGD","SG9999001176.USD","LU0170899867.USD","IE00B19Z3B42.SGD","LU0225284248.USD","SGXZ57979304.SGD","LU0321505439.SGD","LU0456855351.SGD","LU0985481810.HKD","BK4139","LU1894683264.USD","LU1894683348.USD","SG9999002224.SGD","BK4568","BK4592","LU0306806265.USD","BK4082","BK4550","SG9999003800.SGD","LU1057294990.SGD","LU0306807586.USD","SG9999013999.USD","BK4599","LU0225771236.USD","LU0868494617.USD","BK4533","SG9999011175.SGD","LU0122379950.USD","BK4581","MTSR","IE0002270589.USD","SG9999002232.USD","LU1066051498.USD","BK4588","IE00BLSP4239.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0058720904.USD","PFE","LU1023059063.AUD","BK4585","LU0234572021.USD","BK4534","SG9999001176.SGD","IE00B19Z3581.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"1156599852","title":"HHS宣布FDA批准两种新药用于更年期症状","url":"https://stock-news.laohu8.com/highlight/detail?id=1156599852","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156599852?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:18","pubTimestamp":1763572697,"startTime":"0","endTime":"0","summary":"11月10日 - HHS:FDA还批准了两种新药,以拓展更年期症状的治疗选择;FDA并不寻求取消针对单纯系统雌激素产品的子宫内膜癌的盒装警告;FDA为了扩大更年期症状的治疗选项,正在批准一种Premarin(结合雌激素)的仿制药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1066053197.SGD","LU0225771236.USD","BK4550","PFE","LU0225284248.USD","BK4592","SG9999013999.USD","BK4599","BK4534","LU0456855351.SGD","SG9999001176.SGD","LU1066051498.USD","LU0868494617.USD","IE00B19Z3B42.SGD","BK4007","IE00BLSP4239.USD","BK4588","BK4533","LU0122379950.USD","SG9999001176.USD","SG9999003800.SGD","LU0306806265.USD","SG9999002224.SGD","BK4568","SG9999002232.USD","LU0170899867.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU0234572021.USD","LU0321505439.SGD","SG9999011175.SGD","IE00BBT3K403.USD","BK4585","LU0289739699.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU0985481810.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0321505868.SGD","BK4581","LU1023059063.AUD","LU1894683264.USD","IE00B19Z3581.USD","LU1894683348.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"1134214449","title":"辉瑞向Metsera提交了增价收购提案,与诺和诺德的出价相匹配,评估Metsera每股价值为86.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134214449","media":"投资观察","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134214449?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:45","pubTimestamp":1763570719,"startTime":"0","endTime":"0","summary":"11月5日 - 辉瑞已提交其增价收购Metsera的提案,与诺和诺德的出价相匹配,评估Metsera每股价值为86.20美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e1fbf767b72786c619addd4b3b99990","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","SGXZ57979304.SGD","LU0234572021.USD","BK4599","LU0225771236.USD","SG9999002232.USD","BK4533","LU1023059063.AUD","BK4592","LU0170899867.USD","LU1883839398.USD","SG9999002224.SGD","LU0321505439.SGD","LU1057294990.SGD","LU1066053197.SGD","LU1066051498.USD","BK4550","IE00BLSP4452.SGD","SG9999013999.USD","BK4588","IE00B19Z3B42.SGD","BK4139","LU0122379950.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU0868494617.USD","IE000M9KFDE8.USD","LU0058720904.USD","BK4568","LU0306807586.USD","PFE","SG9999001176.USD","BK4585","IE00BBT3K403.USD","LU0306806265.USD","LU1894683264.USD","SG9999003800.SGD","SG9999011175.SGD","BK4581","LU0225284248.USD","MTSR","BK4007","IE0002270589.USD","LU0289739699.SGD","LU0321505868.SGD","LU0985481810.HKD","LU1894683348.USD","BK4534","LU0456855351.SGD"],"gpt_icon":0},{"id":"1138072236","title":"辉瑞与Tris Pharma就德克萨斯州儿童ADHD药物的质量控制问题达成4150万美元和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1138072236","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138072236?lang=zh_cn&edition=full","pubTime":"2025-11-19 23:10","pubTimestamp":1763565017,"startTime":"0","endTime":"0","summary":"辉瑞与Tris Pharma就德克萨斯州儿童ADHD药物的质量控制问题达成4150万美元和解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4581","LU0306807586.USD","LU0225771236.USD","IE00BBT3K403.USD","BK4599","BK4568","IE00B19Z3B42.SGD","IE00BLSP4239.USD","SG9999003800.SGD","LU0456855351.SGD","BK4550","SG9999001176.SGD","LU1023059063.AUD","LU0868494617.USD","LU1066051498.USD","SG9999002232.USD","LU1066053197.SGD","LU1894683264.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999013999.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0321505868.SGD","BK4585","IE00BLSP4452.SGD","BK4533","LU0234572021.USD","LU1894683348.USD","IE0002270589.USD","SG9999002224.SGD","LU0306806265.USD","LU0289739699.SGD","PFE","LU0122379950.USD","BK4592","BK4007","LU0170899867.USD","BK4588","BK4534","LU1057294990.SGD","LU0225284248.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"2584949857","title":"和铂医药-B子公司与辉瑞签非独家授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2584949857","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584949857?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:41","pubTimestamp":1763556080,"startTime":"0","endTime":"0","summary":"11月19日,和铂医药-B(02142)发布公告,本公司全资子公司诺纳生物(苏州)有限公司已与辉瑞订立非独家授权协议,旨在推进针对多种潜在疾病适应症的临床前抗体发现工作。根据协议条款,辉瑞将获得诺纳生物专有HCAb平台的全球使用权,以开发全人源仅重链抗体。诺纳生物将获得首付款,并有权获得监管、临床及商业里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511193568995670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0058720904.USD","BK4581","LU0306807586.USD","LU0225771236.USD","IE00BBT3K403.USD","BK4599","BK4568","IE00B19Z3B42.SGD","IE00BLSP4239.USD","SG9999003800.SGD","LU0456855351.SGD","BK4550","SG9999001176.SGD","LU1023059063.AUD","LU0868494617.USD","LU1066051498.USD","SG9999002232.USD","LU1066053197.SGD","LU1894683264.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999013999.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0321505868.SGD","BK1574","BK4585","BK4533","IE00BLSP4452.SGD","LU0234572021.USD","LU1894683348.USD","IE0002270589.USD","02142","LU0306806265.USD","SG9999002224.SGD","LU0289739699.SGD","PFE","LU0122379950.USD","BK1583","BK4592","BK4007","LU0170899867.USD","BK4588","BK4534","LU1057294990.SGD","LU0225284248.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"1183080096","title":"Nona Biosciences:可能与辉瑞合作进行抗体发现、开发和工程,利用Nona的Hcab平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1183080096","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183080096?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:10","pubTimestamp":1763554215,"startTime":"0","endTime":"0","summary":"Nona Biosciences:可能与辉瑞合作进行抗体发现、开发和工程,利用Nona的Hcab平台","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1066051498.USD","LU0122379950.USD","LU0170899867.USD","LU0225284248.USD","SG9999002224.SGD","LU1057294990.SGD","LU1066053197.SGD","IE0002270589.USD","BK4588","BK4599","BK4568","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1894683264.USD","BK4581","BK4585","LU0234572021.USD","SGXZ57979304.SGD","LU0289739699.SGD","IE00BBT3K403.USD","SG9999003800.SGD","BK4533","LU0058720904.USD","LU0225771236.USD","SG9999011175.SGD","PFE","BK4550","BK4534","IE00B19Z3581.USD","SG9999001176.SGD","LU1023059063.AUD","LU1883839398.USD","LU1894683348.USD","LU0456855351.SGD","SG9999002232.USD","LU0868494617.USD","LU0321505868.SGD","IE000M9KFDE8.USD","SG9999001176.USD","SG9999013999.USD","LU0985481810.HKD","LU0306806265.USD","LU0306807586.USD","BK4592","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"1117739001","title":"辉瑞 - Nona Biosciences将获得预付款并有资格获得监管、临床和商业里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1117739001","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117739001?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:10","pubTimestamp":1763554215,"startTime":"0","endTime":"0","summary":"辉瑞 - Nona Biosciences将获得预付款并有资格获得监管、临床和商业里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1066051498.USD","LU0122379950.USD","LU0170899867.USD","LU0225284248.USD","SG9999002224.SGD","LU1057294990.SGD","LU1066053197.SGD","IE0002270589.USD","BK4588","BK4599","BK4568","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1894683264.USD","BK4581","BK4585","LU0234572021.USD","SGXZ57979304.SGD","LU0289739699.SGD","IE00BBT3K403.USD","SG9999003800.SGD","BK4533","LU0058720904.USD","LU0225771236.USD","SG9999011175.SGD","PFE","BK4550","BK4534","IE00B19Z3581.USD","SG9999001176.SGD","LU1023059063.AUD","LU1883839398.USD","LU1894683348.USD","LU0456855351.SGD","SG9999002232.USD","LU0868494617.USD","LU0321505868.SGD","IE000M9KFDE8.USD","SG9999001176.USD","SG9999013999.USD","LU0985481810.HKD","LU0306806265.USD","LU0306807586.USD","BK4592","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"1120715116","title":"Nona Biosciences与辉瑞宣布战略研究合作 加速抗体发现","url":"https://stock-news.laohu8.com/highlight/detail?id=1120715116","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120715116?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:09","pubTimestamp":1763554155,"startTime":"0","endTime":"0","summary":"Nona Biosciences与辉瑞宣布战略研究合作 加速抗体发现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0456855351.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1883839398.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","SG9999003800.SGD","IE00B19Z3581.USD","PFE","BK4588","LU0306806265.USD","LU0321505439.SGD","LU0306807586.USD","LU0289739699.SGD","BK4533","SG9999002232.USD","BK4550","LU0122379950.USD","LU0868494617.USD","LU0985481810.HKD","IE00BLSP4452.SGD","BK4599","SG9999001176.SGD","BK4568","SG9999001176.USD","IE0002270589.USD","BK4007","LU1894683348.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0225771236.USD","BK4592","LU0234572021.USD","SG9999013999.USD","BK4581","LU0170899867.USD","LU0321505868.SGD","SG9999011175.SGD","LU0058720904.USD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","IE00BLSP4239.USD","BK4534","LU1894683264.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"1143519400","title":"Nona Bioscience:辉瑞将获得全球使用Nona专有Hcab平台的权利,以生成完全人类重链抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=1143519400","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143519400?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:09","pubTimestamp":1763554155,"startTime":"0","endTime":"0","summary":"Nona Bioscience:辉瑞将获得全球使用Nona专有Hcab平台的权利,以生成完全人类重链抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4585","LU0122379950.USD","LU0225771236.USD","LU0321505439.SGD","IE0002270589.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","BK4534","LU0170899867.USD","BK4588","IE00BLSP4239.USD","SG9999002224.SGD","IE00BBT3K403.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU1057294990.SGD","BK4599","SG9999013999.USD","LU0058720904.USD","BK4581","BK4568","BK4550","LU1023059063.AUD","SG9999001176.USD","BK4007","LU0306806265.USD","BK4533","LU1894683264.USD","LU1883839398.USD","LU1066053197.SGD","LU0456855351.SGD","SG9999002232.USD","LU0225284248.USD","BK4592","PFE","LU0306807586.USD","LU0321505868.SGD","SG9999003800.SGD","SGXZ57979304.SGD","LU0868494617.USD"],"gpt_icon":0},{"id":"1129401181","title":"辉瑞公布55亿美元六期债券的定价条款; 2027年到期的5亿美元浮动利率债券 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1129401181","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129401181?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:06","pubTimestamp":1763550371,"startTime":"0","endTime":"0","summary":"辉瑞公布55亿美元六期债券的定价条款; 2027年到期的5亿美元浮动利率债券 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1066051498.USD","LU0122379950.USD","LU0170899867.USD","LU0225284248.USD","SG9999002224.SGD","LU1057294990.SGD","LU1066053197.SGD","IE0002270589.USD","BK4588","BK4599","BK4568","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1894683264.USD","BK4581","BK4585","LU0234572021.USD","SGXZ57979304.SGD","LU0289739699.SGD","IE00BBT3K403.USD","SG9999003800.SGD","BK4533","LU0058720904.USD","LU0225771236.USD","SG9999011175.SGD","PFE","BK4550","BK4534","IE00B19Z3581.USD","SG9999001176.SGD","LU1023059063.AUD","LU1883839398.USD","LU1894683348.USD","LU0456855351.SGD","SG9999002232.USD","LU0868494617.USD","LU0321505868.SGD","IE000M9KFDE8.USD","SG9999001176.USD","SG9999013999.USD","LU0985481810.HKD","LU0306806265.USD","LU0306807586.USD","BK4592","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2584005996","title":"辉瑞(PFE.US)拟发行50亿美元债券 为收购减肥药企Metsera筹措资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2584005996","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584005996?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:58","pubTimestamp":1763521135,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据知情人士透露,辉瑞正计划通过发行美元公司债券募集至少50亿美元资金,部分用于资助近期对肥胖症药物研发公司Metsera的收购交易。据了解,周二当天,辉瑞与其他八家机构一同启动投资级债券发行融资。此前一日,受亚马逊150亿美元投资级债券发行推动,市场完成了263亿美元的融资交易。这家新冠疫苗研发企业经过激烈竞标,最终以最高100亿美元的对价完成对Metsera的收购,其中包含与或有价值权利挂钩的每股20.65美元现金额外付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1057294990.SGD","SG9999011175.SGD","LU1894683264.USD","SG9999013999.USD","LU0234572021.USD","BK4592","LU1023059063.AUD","LU1066053197.SGD","SGXZ57979304.SGD","BK4007","LU0289739699.SGD","LU0321505439.SGD","LU0321505868.SGD","LU0170899867.USD","IE00BLSP4239.USD","PFE","BK4599","LU1894683348.USD","LU0122379950.USD","SG9999001176.SGD","LU0456855351.SGD","BK4588","LU0058720904.USD","SG9999001176.USD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4550","IE000M9KFDE8.USD","LU1883839398.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","LU0306806265.USD","BK4585","LU0868494617.USD","LU0985481810.HKD","BK4581","BK4139","BK4533","LU0225771236.USD","MTSR","SG9999003800.SGD","IE0002270589.USD","LU0225284248.USD","BK4534","BK4568","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"1114829190","title":"预计11月19日在华盛顿举行的美沙投资论坛将包括雪佛龙、高通、思科、通用动力和辉瑞的首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1114829190","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114829190?lang=zh_cn&edition=full","pubTime":"2025-11-18 06:48","pubTimestamp":1763419693,"startTime":"0","endTime":"0","summary":"预计11月19日在华盛顿举行的美沙投资论坛将包括雪佛龙、高通、思科、通用动力和辉瑞的首席执行官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6976171828aa5c3c803b34276eee00d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4581","LU0225771236.USD","LU1261432733.SGD","LU1974910355.USD","IE00BBT3K403.USD","IE00BVYPNP33.GBP","LU2133065610.SGD","BK4550","IE00B1BXHZ80.USD","LU0098860793.USD","LU2506952170.USD","SGXZ57979304.SGD","BK4570","LU1674673691.USD","LU0823417653.USD","BK4515","GB00BDT5M118.USD","IE00B2Q91V27.USD","LU0654597011.USD","LU0122376428.USD","LU0070302665.USD","BK4533","LU1162221912.USD","IE0002270589.USD","IE00BVYPNV92.GBP","LU0792757196.USD","LU0950375773.USD","LU1506573853.SGD","LU0868494708.USD","LU0203345920.USD","BK4525","LU2129689514.USD","BK4187","SG9999015978.USD","IE00B3CCJ963.GBP","LU1046421795.USD","QCOM","SG9999001176.USD","LU1119994496.HKD","SG9999002521.SGD","LU1430594728.SGD","CVX","LU0320765489.SGD","LU0731783394.SGD","LU0306807586.USD","LU1221951129.SGD","LU2417539215.USD","BK4568","IE00B19Z3B42.SGD","LU0203347892.USD","SG9999003800.SGD","IE00BGHQDM52.EUR","SG9999002232.USD","IE00B19Z3581.USD","LU1496350502.SGD","LU0079474960.USD","LU0265550359.USD","LU1035775433.USD","LU0640476718.USD","CSCO","LU0345780950.USD","LU2286300806.USD","BK4585","LU2237443622.USD","LU0348723411.USD","SG9999002224.SGD","LU0306806265.USD","LU0368265418.SGD","IE00B3T34201.USD","BK4020","IE00BVYPNQ40.USD","LU1069344957.HKD","IE00BZ1G4Q59.USD","LU0170899867.USD","BK4561","LU1929549753.HKD","LU2237443382.USD","LU0321505439.SGD","LU1066051811.HKD","LU1778281490.HKD","LU2462157665.USD","IE00BDGV0183.EUR","LU0300736062.USD","LU1267930813.SGD","LU2506952097.USD","IE00B7SZLL34.SGD","BK4604","LU1599440770.SGD","BK4560","LU1883839398.USD","LU2129689431.USD","IE00B3PB1722.GBP","SG9999015945.SGD","IE00BFXG1179.USD","LU2247934214.USD","LU1823568750.SGD","SG9999001176.SGD","LU2506951875.HKD","LU1894683264.USD","LU2237438978.USD","LU1032955483.USD","LU0456854461.SGD","LU1196500208.SGD","GD","IE00B42XCP33.USD","LU0417517546.SGD","LU1059921491.USD","LU2023250504.SGD","SG9999001424.SGD","LU0256863811.USD","SG9999001440.SGD","SG9999011175.SGD","BK4527","BK4532","LU0061475181.USD","LU2456880835.USD","LU0300736492.USD","IE000M9KFDE8.USD","LU0985481810.HKD","LU1084165304.USD","LU2236285917.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU1280957306.USD","PFE","LU0266512127.USD","BK4598","BK4592","LU1244550221.USD","LU1585245621.USD","BK4516","IE00BKVL7J92.USD","BK4579","LU0225284248.USD","BK4605","LU2237443549.SGD","BK4575","IE00BVYPNW00.USD","LU0208291251.USD","LU0278409577.USD","LU1235294995.USD","LU2237443978.SGD","LU0265550946.USD","LU0345781412.USD","LU0320765646.SGD","LU1066051225.USD","LU1880398554.USD","BK4599","LU1917777945.USD","LU0823417737.USD","IE00BLSP4239.USD","SG9999015986.USD","BK4141","BK4612","LU0456855351.SGD","LU1116320901.HKD","LU2237443465.HKD","LU0788109394.HKD","LU1023059063.AUD","LU0868494617.USD","LU1066051498.USD","LU1674673428.USD","LU2106854487.HKD","LU1066053197.SGD","BK4566","LU1221951046.USD","LU2381873111.SGD","BK4559","LU0630314457.HKD","LU1880398471.USD","LU2129689605.HKD","SG9999015952.SGD","LU0612318385.USD","LU1571399168.USD","LU0321505868.SGD","IE00BFMHRM44.USD","LU1116320737.USD","BK4573","LU1074936037.SGD","LU1894683348.USD","LU2506951958.HKD","LU1244550494.USD","LU0289739699.SGD","IE00BGHQF524.EUR","LU1244550577.SGD","LU0081259029.USD","LU0122379950.USD","LU1496350171.SGD","BK4512","LU0234570918.USD","BK4007","BK4534","BK4588","IE00BSNM7G36.USD","LU0942090050.USD","LU1057294990.SGD","LU0612318971.USD","LU2237443895.HKD","BK4554","LU0889566641.SGD","LU1430597077.USD","BK4201","IE00BGHQF631.EUR","SG9999013999.USD"],"gpt_icon":0},{"id":"1107999079","title":"异动解读 | 辉瑞斥资100亿美元收购减肥药新贵,股价盘前大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107999079","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107999079?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:02","pubTimestamp":1763125379,"startTime":"0","endTime":"0","summary":"美国制药巨头辉瑞在盘前交易中股价大跌5%,引发市场关注。据报道,辉瑞以近100亿美元的高价成功收购了减肥药新贵公司Metsera。对辉瑞而言,这次收购是一场战略性的突围。在高速增长的减重市场上,辉瑞几乎处于\"缺位\"状态。尽管辉瑞此举旨在快速进入蓬勃发展的减重药市场,但100亿美元的收购价格是否物有所值,以及能否为公司带来预期的回报,仍然存在不确定性。这些因素可能是导致辉瑞股价在盘前大幅下跌的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PFE"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0462},{"period":"6month","weight":0.1148},{"period":"1year","weight":0.0128},{"period":"ytd","weight":-0.0188}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源,通过发现、开发、制造和分销保健产品(包括创新药物和疫苗),为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作,致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作,支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.001224},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007083},{"month":3,"riseRate":0.6,"avgChangeRate":0.014714},{"month":4,"riseRate":0.586957,"avgChangeRate":0.018253},{"month":5,"riseRate":0.5,"avgChangeRate":0.007748},{"month":6,"riseRate":0.5,"avgChangeRate":0.002798},{"month":7,"riseRate":0.478261,"avgChangeRate":0.011357},{"month":8,"riseRate":0.456522,"avgChangeRate":0.0002},{"month":9,"riseRate":0.456522,"avgChangeRate":0.004432},{"month":10,"riseRate":0.630435,"avgChangeRate":0.013042},{"month":11,"riseRate":0.695652,"avgChangeRate":0.028255},{"month":12,"riseRate":0.521739,"avgChangeRate":0.009406}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}